APA (7th ed.) Citation

Vourvahis, M., Wang, R., Ndongo, M., O'Gorman, M., & Tawadrous, M. (2012). No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects. Antimicrobial Agents and Chemotherapy, 56(5), 2408-2413. https://doi.org/10.1128/AAC.05194-11

Chicago Style (17th ed.) Citation

Vourvahis, Manoli, Rong Wang, Marie-Noella Ndongo, Melissa O'Gorman, and Margaret Tawadrous. "No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects." Antimicrobial Agents and Chemotherapy 56, no. 5 (2012): 2408-2413. https://doi.org/10.1128/AAC.05194-11.

MLA (9th ed.) Citation

Vourvahis, Manoli, et al. "No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects." Antimicrobial Agents and Chemotherapy, vol. 56, no. 5, 2012, pp. 2408-2413, https://doi.org/10.1128/AAC.05194-11.